| Product Code: ETC12838778 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Andorra Influenza Vaccines Market Overview |
3.1 Andorra Country Macro Economic Indicators |
3.2 Andorra Influenza Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Andorra Influenza Vaccines Market - Industry Life Cycle |
3.4 Andorra Influenza Vaccines Market - Porter's Five Forces |
3.5 Andorra Influenza Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Andorra Influenza Vaccines Market Revenues & Volume Share, By Strain Type, 2021 & 2031F |
3.7 Andorra Influenza Vaccines Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.8 Andorra Influenza Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Andorra Influenza Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of influenza vaccination in Andorra |
4.2.2 Government initiatives promoting influenza vaccination programs |
4.2.3 Growing elderly population in Andorra, who are more susceptible to influenza |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas of Andorra |
4.3.2 High cost associated with influenza vaccines |
4.3.3 Seasonal nature of demand for influenza vaccines |
5 Andorra Influenza Vaccines Market Trends |
6 Andorra Influenza Vaccines Market, By Types |
6.1 Andorra Influenza Vaccines Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Andorra Influenza Vaccines Market Revenues & Volume, By Vaccine Type, 2021 - 2031F |
6.1.3 Andorra Influenza Vaccines Market Revenues & Volume, By Inactivated Influenza Vaccine (IIV), 2021 - 2031F |
6.1.4 Andorra Influenza Vaccines Market Revenues & Volume, By Live Attenuated Influenza Vaccine (LAIV), 2021 - 2031F |
6.1.5 Andorra Influenza Vaccines Market Revenues & Volume, By Recombinant Influenza Vaccine, 2021 - 2031F |
6.2 Andorra Influenza Vaccines Market, By Strain Type |
6.2.1 Overview and Analysis |
6.2.2 Andorra Influenza Vaccines Market Revenues & Volume, By Trivalent Vaccines, 2021 - 2031F |
6.2.3 Andorra Influenza Vaccines Market Revenues & Volume, By Quadrivalent Vaccines, 2021 - 2031F |
6.3 Andorra Influenza Vaccines Market, By Age Group |
6.3.1 Overview and Analysis |
6.3.2 Andorra Influenza Vaccines Market Revenues & Volume, By Pediatric, 2021 - 2031F |
6.3.3 Andorra Influenza Vaccines Market Revenues & Volume, By Adult, 2021 - 2031F |
6.3.4 Andorra Influenza Vaccines Market Revenues & Volume, By Geriatric, 2021 - 2031F |
6.4 Andorra Influenza Vaccines Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Andorra Influenza Vaccines Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.4.3 Andorra Influenza Vaccines Market Revenues & Volume, By Nasal Spray, 2021 - 2031F |
7 Andorra Influenza Vaccines Market Import-Export Trade Statistics |
7.1 Andorra Influenza Vaccines Market Export to Major Countries |
7.2 Andorra Influenza Vaccines Market Imports from Major Countries |
8 Andorra Influenza Vaccines Market Key Performance Indicators |
8.1 Percentage increase in influenza vaccination coverage in Andorra |
8.2 Number of influenza vaccination campaigns conducted annually |
8.3 Rate of adherence to influenza vaccination guidelines among healthcare professionals in Andorra |
9 Andorra Influenza Vaccines Market - Opportunity Assessment |
9.1 Andorra Influenza Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Andorra Influenza Vaccines Market Opportunity Assessment, By Strain Type, 2021 & 2031F |
9.3 Andorra Influenza Vaccines Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.4 Andorra Influenza Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Andorra Influenza Vaccines Market - Competitive Landscape |
10.1 Andorra Influenza Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Andorra Influenza Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here